Sage Therapeutics, which is developing treatments for life-threatening epileptic seizures, raised the proposed deal size for its upcoming IPO on Thursday. The Cambridge, MA-based company now plans to raise $88 million by offering 5 million shares at a price range of $17 to $18. The company had previously filed to offer 4 million shares at a range of $14 to $16.
At the midpoint of the revised range, Sage Therapeutics will raise 46% greater proceeds than previously anticipated at a market cap of $463 million, up 21% from its prior $382 million market cap.
Help employers find you! Check out all the jobs and post your resume.
